Showing results (1411-1420 of 2,537) with videos related to
Sort By:
Pageof 254
Environmental Pollution (Barking, Essex : 1987)|February 9, 2016
Long-term variation of black carbon and PM2.5 in Beijing, China with respect to meteorological conditions and governmental measuresYuan Chen, Nina Schleicher, Mathieu Fricker, et al.International Journal of Clinical and Experimental Pathology|January 23, 2020
The regulatory role of Mcl-1 in apoptosis of mouse peritoneal macrophage infected with M. tuberculosis strains that differ in virulenceXiaofang Wang, Xinmin Wang, Le Zhang, et al.The Journal of Obstetrics and Gynaecology Research|January 5, 2021
Prediction of live birth probability after in vitro fertilization and intracytoplasmic sperm injection treatment: A multi-center retrospective study in Chinese populationMingyang Wen, Fang Wu, Jiangbo Du, et al.Digestive Surgery|November 17, 2021
Identification and Validation of Hub Genes Predicting Prognosis of Hepatocellular CarcinomaZiyan Chen, Haitao Yu, Lijun Wu, et al.Journal of Cellular and Molecular Medicine|November 11, 2021
Association between non-alcoholic fatty liver disease with the susceptibility and outcome of COVID-19: A retrospective studyGuyi Wang, Shangjie Wu, Chenfang Wu, et al.Aging Medicine (Milton (N.S.W))|October 17, 2022
Chinese expert consensus on assessment of cognitive impairment in the elderlyXiushi Ni, Fang Wu, Juan Song, et al.Fitoterapia|April 13, 2021
Neolinulicin A and B from Inula japonica and their anti-inflammatory activitiesRui-Fang Wu, Bing-Duo Zhou, Wen-Qiong Wang, et al.Journal of Ethnopharmacology|October 5, 2025
Lycium barbarum polysaccharide LBP-4 attenuates triptolide-induced male reproductive toxicity via Nrf2/Keap1-mediated antioxidant response and apoptotic regulationZechao Wang, Jixin Xie, Fang Wu, et al.International Journal of Nanomedicine|August 11, 2025
Nanomedicines in the Treatment of Liver Fibrosis: A ReviewXiao Du, Runyan Niu, Xuexue Liu, et al.Frontiers in Pharmacology|March 5, 2025
Pharmacovigilance analysis of polatuzumab plus bendamustine and rituximab treatment protocol: identifying comprehensive safety signals using FDA databaseFang Wu, Siliang Wang, Xihui Xu, et al.Pageof 254